Omega Healthcare Investors (OHI) Issues FY18 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY18 earnings guidance on Monday. The company provided EPS guidance of $3.03-3.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.01. Omega Healthcare Investors also updated its FY 2018 guidance to $3.03-3.06 EPS.

A number of analysts have recently issued reports on the company. Stifel Nicolaus set a $34.00 target price on Omega Healthcare Investors and gave the stock a hold rating in a research report on Monday. MED lifted their target price on Omega Healthcare Investors to $34.00 and gave the stock a neutral rating in a research report on Monday. Zacks Investment Research raised Omega Healthcare Investors from a sell rating to a hold rating in a research report on Wednesday, October 31st. Mitsubishi UFJ Financial Group reaffirmed a neutral rating on shares of Omega Healthcare Investors in a research report on Tuesday, October 2nd. Finally, ValuEngine raised Omega Healthcare Investors from a sell rating to a hold rating in a research report on Monday, August 13th. Nine equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of $31.17.

Shares of NYSE OHI traded up $0.40 during midday trading on Wednesday, reaching $34.85. 23,600 shares of the company’s stock were exchanged, compared to its average volume of 1,937,807. Omega Healthcare Investors has a 52-week low of $24.90 and a 52-week high of $34.94. The firm has a market cap of $6.56 billion, a price-to-earnings ratio of 10.56, a PEG ratio of 5.51 and a beta of 0.13. The company has a debt-to-equity ratio of 1.15, a quick ratio of 4.03 and a current ratio of 4.03.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Monday, November 5th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.74 by ($0.46). The firm had revenue of $192.30 million during the quarter, compared to the consensus estimate of $194.40 million. Omega Healthcare Investors had a net margin of 10.61% and a return on equity of 2.49%. The firm’s quarterly revenue was down .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.79 earnings per share. As a group, research analysts predict that Omega Healthcare Investors will post 2.97 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 15th. Investors of record on Wednesday, October 31st will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 7.58%. The ex-dividend date of this dividend is Tuesday, October 30th. Omega Healthcare Investors’s dividend payout ratio is currently 80.00%.

TRADEMARK VIOLATION WARNING: This report was first posted by WKRB News and is the property of of WKRB News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.wkrb13.com/2018/11/07/omega-healthcare-investors-ohi-issues-fy18-earnings-guidance.html.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: Compound Interest and Why It Matters When Investing

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply